Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
Julianne Gee, Eric Weintraub, Matthew F. Daley(Kaiser Permanente), Irene M. Shui(Harvard University), James Baggs, Nicola P. Klein, Allison L. Naleway(Centers for Disease Control and Prevention), Bruce Fireman(Kaiser Permanente), Rong Li(Peking University), Ruihua Yin(Qingdao University), Edwin Lewis(Kaiser Permanente), Martin Kulldorff(Harvard Pilgrim Health Care)
Cited by 228
Related Papers
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Single-Cell RNA-Seq Analysis Maps Development of Human Germline Cells and Gonadal Niche Interactions
|Cell stem cell|2017|616
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602